Work

Abstract OT2-09-01: Pilot study of denosumab in BRCA1/2 mutation carriers scheduling for risk-reducing salpingo-oophorectomy

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs18-ot2-09-01

Authors: MS Trivedi, G Samimi, JD Wright, K Holcomb, JE Garber, NS Horowitz, N Arber, E Friedman, RM Wenham, M House, H Parnes, JJ Lee, S Abutaseh, LA Vornik, BM Heckman-Stoddard, PH Brown, KD Crew

Institutions: Brigham and Women's Hospital, National Institutes of Health, The University of Texas MD Anderson Cancer Center, Columbia University Irving Medical Center, Tel Aviv Sourasky Medical Center, Sheba Medical Center, Moffitt Cancer Center, Dana-Farber Cancer Institute, National Cancer Institute, Weill Cornell Medical Center

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2943867225

Cites:

Cited by: 2

Related to: 10